The partnership, now in its second year, features a limited-edition T-shirt and the Body Check Cup in order to encourage more cancer screenings.

The logo of US pharmaceutical company Pfizer at the 7th China International Import ... British pharmaceutical giant AstraZeneca signed a landmark agreement earlier this month to invest $2.5 billion in ...

AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical Research and ...

BTIG notes that shares of Tempus AI (TEM) are up on news that the company signed a $200M expanded strategic agreement with AstraZeneca (AZN) ...

The AstraZeneca PLC ADR AZN advanced 1.52% to $69.55 Thursday, on what proved to be an all-around positive trading session ...

AstraZeneca PLC ADR closed 22.59% below its 52-week high of $87.68, which the company achieved on August 30th.

LONDON, April 23 (Reuters) - AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending it now must do the same and invest more ...

Tempus stands to earn $200 million in data licensing and model development fees from the collaborations, the release said.

CEO Pascal Soriot said Europe was "falling behind" in attracting investment and needed to "invest more in what really matters ...

Tempus AI has signed a three-way deal with AstraZeneca and Pathos AI to construct a data-based oncology model that could ...